p27KlP1 expression in metastatic and non-metastatic pancreatic endocrine neoplasms

被引：0
|
作者：
Rahman, A
Maitra, A
Yeo, CJ
Cameron, JL
Hruban, RH
Ashfaq, R
Hansel, DE
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] Univ Texas, SW Med Ctr, Dallas, TX USA
来源：
LABORATORY INVESTIGATION | 2003年 / 83卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1296
引用
收藏
页码：284A / 284A
页数：1
相关论文
共 50 条
  • [41] CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas
    Lueke, Julia
    Vukoja, Vlatka
    Brandenbusch, Tim
    Nassar, Khaled
    Rohrbach, Jens Martin
    Grisanti, Salvatore
    Lueke, Matthias
    Tura, Ayseguel
    BMC OPHTHALMOLOGY, 2016, 16
  • [42] Gene expression profile comparison between bone metastatic and non-metastatic prostate cancer cell lines
    Docherty, Freyja
    Fowles, Anne
    Eaton, Colby
    Wang, Ning
    PURINERGIC SIGNALLING, 2014, 10 (04) : 834 - 835
  • [43] Expression of CD44 splice variants in metastatic and non-metastatic mouse tumour cell lines
    Tkach, T
    Li, EQ
    Bestagno, M
    Burrone, OR
    IMMUNOLOGY LETTERS, 1996, 52 (2-3) : 81 - 87
  • [44] Comparison of immunohistochemical characteristics of prognostic markers expression in non-metastatic and metastatic invasive endometrioid endometrial carcinoma
    Chepets, A. V.
    ZAPOROZHYE MEDICAL JOURNAL, 2016, (05) : 58 - 63
  • [45] CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas
    Julia Lüke
    Vlatka Vukoja
    Tim Brandenbusch
    Khaled Nassar
    Jens Martin Rohrbach
    Salvatore Grisanti
    Matthias Lüke
    Aysegül Tura
    BMC Ophthalmology, 16
  • [46] Expression of urokinase and urinary trypsin inhibitor in metastatic and non-metastatic murine Lewis lung carcinoma cells
    Kobayashi, H
    Gotoh, J
    Hirashima, Y
    Terao, T
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 8 (04) : 757 - 763
  • [47] Selecting patients for resection after primary chemotherapy for non-metastatic pancreatic adenocarcinoma
    Reni, M.
    Zanon, S.
    Balzano, G.
    Nobile, S.
    Pircher, C. C.
    Chiaravalli, M.
    Passoni, P.
    Arcidiacono, P. G.
    Nicoletti, R.
    Crippa, S.
    Slim, N.
    Doglioni, C.
    Falconi, M.
    Gianni, L.
    ANNALS OF ONCOLOGY, 2017, 28 (11) : 2786 - 2792
  • [48] Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinoma
    Labiano, Ibone
    Huerta, Ana E.
    Alsina, Maria
    Arasanz, Hugo
    Castro, Natalia
    Mendaza, Saioa
    Lecumberri, Arturo
    Gonzalez-Borja, Iranzu
    Guerrero-Setas, David
    Patino-Garcia, Ana
    Alkorta-Aranburu, Gorka
    Hernandez-Garcia, Irene
    Arrazubi, Virginia
    Mata, Elena
    Gomez, David
    Viudez, Antonio
    Vera, Ruth
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [49] Locally advanced non-metastatic pancreatic cancer - Can we do more?
    Hawkins, M. A.
    Tait, D.
    CLINICAL ONCOLOGY, 2008, 20 (07) : 532 - 534
  • [50] Identifying Prohibitive Risk Factors for Resection in Non-Metastatic Pancreatic Neuroendocrine Tumors
    Heidenreich, B. M.
    Bader, J. M.
    O'Connor, V. V.
    Nelson, D. W.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S144 - S144
12345